(Q42478119)

English

Imiquimod 5% cream for the treatment of superficial basal cell carcinoma: results from a randomized vehicle-controlled phase III study in Europe

scientific article published on May 2005

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

Imiquimod 5% cream for the treatment of superficial basal cell carcinoma: results from a randomized vehicle-controlled phase III study in Europe (English)

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

superficial basal cell carcinoma

1 reference

based on heuristic

inferred from title

author name string

H J Schulze

1

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

B Cribier

2

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

L Requena

3

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

J Reifenberger

4

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

C Ferrándiz

5

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

A Garcia Diez

6

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

V Tebbs

7

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

S McRae

8

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

language of work or name

0 references

publication date

1 May 2005

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

British Journal of Dermatology

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

152

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

5

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

939-947

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

Basal cell carcinoma

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2005.06486.X

21 January 2018

bcl-2 Expression in Primary Malignancies of the Skin

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2005.06486.X

21 January 2018

p53 activates the CD95 (APO-1/Fas) gene in response to DNA damage by anticancer drugs

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2005.06486.X

21 January 2018

Review Article Imiquimod applied topically: a novel immune response modifier and new class of drug

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2005.06486.X

21 January 2018

Small anti-viral compounds activate immune cells via the TLR7 MyD88-dependent signaling pathway

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2005.06486.X

21 January 2018

Imiquimod 5% cream in the treatment of superficial basal cell carcinoma: results of a multicenter 6-week dose-response trial

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2005.06486.X

21 January 2018

Imiquimod 5% cream for the treatment of superficial basal cell carcinoma: a double-blind, randomized, vehicle-controlled study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2005.06486.X

21 January 2018

The validity and practicality of sun-reactive skin types I through VI.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2005.06486.X

21 January 2018

Imiquimod 5% cream for the treatment of superficial basal cell carcinoma: results from two phase III, randomized, vehicle-controlled studies

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2005.06486.X

21 January 2018

Tumor-selective induction of apoptosis and the small-molecule immune response modifier imiquimod

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2005.06486.X

21 January 2018

Death receptor-independent apoptosis in malignant melanoma induced by the small-molecule immune response modifier imiquimod

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2005.06486.X

21 January 2018

Identifiers

10.1111/J.1365-2133.2005.06486.X

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q42478119&oldid=1958917830"